Cabaletta Bio, Inc.
CABA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001759138
No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Cabaletta Bio, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 62 | 55 | −7 |
| Shares | 18.2M | 16.8M | −1.38M (−7.6%) |
| Value | $36.9M | $17.8M | −$19.1M (−51.7%) |
New holders (5)
Institutions that held Cabaletta Bio, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DLD Asset Management, LP | 246,500 | $261.0K | 0.02% |
| Piper Sandler & Co. | 145,000 | $154.0K | 0.14% |
| Crestline Management, LP | 21,881 | $23.0K | 0.00% |
| Jane Street Group, LLC | 11,158 | $12.0K | 0.00% |
| Howe & Rusling Inc | 100 | $0 | 0.00% |
Sold out (12)
Institutions that held Cabaletta Bio, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 725,000 | $1.47M |
| OrbiMed Advisors LLC | 577,509 | $1.17M |
| Ci Investments Inc. | 129,010 | $262.0K |
| Caption Management, LLC | 52,750 | $106.0K |
| Walleye Capital LLC | 30,507 | $62.0K |
| Allspring Global Investments Holdings, LLC | 21,381 | $43.0K |
| SG3 Management, LLC | 20,000 | $41.0K |
| Dynamic Technology Lab Private Ltd | 19,250 | $39.0K |
| Powell Investment Advisors, LLC | 15,000 | $30.0K |
| Marshall Wace, LLP | 12,718 | $26.0K |
| Virtu Financial LLC | 12,475 | $25.0K |
| Prospera Financial Services Inc | 100 | $0 |